Teladoc Health reported a 3% year-over-year revenue increase to $646.1 million for Q1 2024. The company's net loss was $81.9 million, or $0.49 per share, while adjusted EBITDA increased by 20% year-over-year to $63.1 million.
Revenue grew 3% year-over-year to $646.1 million.
Net loss was $81.9 million, or $0.49 per share.
Adjusted EBITDA increased 20% year-over-year to $63.1 million.
Integrated Care segment revenue increased 8% while BetterHelp segment revenue decreased 4%.
Teladoc Health provides an outlook based on current market conditions and expectations. For the second quarter of 2024, revenue is expected to be between $635 and $660 million, and adjusted EBITDA is expected to be between $70 and $80 million. For the full year of 2024, revenue is expected to be between $2,635 and $2,735 million, and adjusted EBITDA is expected to be between $350 and $390 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance